References
- FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
- SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin20156552925559415
- ZengHZQuYQLiangABExpression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistanceNeoplasma201158544945421745000
- NagashimaSSakuraiKSuzukiSCD147 expression in noninvasive and invasive breast carcinomaGan To Kagaku Ryoho2014411267126925335713
- GrassGDTooleBPHow, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activityBiosci Rep2015361e0028326604323
- ZhuHZhaoJZhuBEMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancerProstate2012721728121563192
- Bilgin DoğruEDizdarYAkşitEUralFŞanlıÖYasaseverVEMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective studyTumour Biol20143511116471165325139103
- BaumanTMEwaldJAHuangWRickeWACD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic featuresBMC Cancer20151554926209327
- GruppKHohneTSPrienKReduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyExp Mol Pathol201395222723423948277
- StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) groupJAMA20002832008201210789670
- StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol20102560360520652370
- ZhangPZhongZHYuHTLiuBSignificance of increased leptin expression in osteoarthritis patientsPLoS One2015104e012322425893833
- HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Available from: http://www.cochrane.org/resources/handbook/hbook.htmAccessed April 26, 2016
- JacksonDWhiteIRRileyRDQuantifying the impact of between-study heterogeneity in multivariate meta-analysesStat Med201231293805382022763950
- PetersJLSuttonAJJonesDRAbramsKRRushtonLComparison of two methods to detect publication bias in meta-analysisJAMA200629567668016467236
- HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ200332755756012958120
- ZintzarasEIoannidisJPHEGESMA: genome search meta-analysis and heterogeneity testingBioinformatics200521183672367315955784
- HanZDBiXCQinWJCD147 expression indicates unfavourable prognosis in prostate cancerPathol Oncol Res200915336937419048397
- HeHCHanZDDaiQSExpression and significance of CDl47 protein inprostate cancerZhonghua Yi Xue Za Zhi2009891844184619953931
- BiXCLiuJMZhengXGOver-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomyClin Invest Med2011346E35822129926
- WangQZhangJGWangWExpression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stagesGenet Mol Res2015146844685126125892
- FengMEFengLTo investigate the expression of the STAT3 and CD147 in human prostate cancerJ Nanchang Univ2010501215
- CaiCYWuCYYangYFLiSRShiXMExpression and clinical significance of CD147 protein in human prostate cancerJ Clin Res20153220882090
- MadiganMCKingsleyEACozziPJDelpradoWJRussellPJLiYThe role of extracellular matrix metalloproteinase inducer protein in prostate cancer progressionCancer Immunol Immunother20085791367137918273614
- Pértega-GomesNVizcaínoJRMiranda-GonçalvesVMonocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancerBMC Cancer20111131221787388
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin20166673026742998
- BoydLKMaoXLuYJThe complexity of prostate cancer: genomic alterations and heterogeneityNat Rev Urol201291165266423132303
- MonteiroLSDelgadoMLRicardoSEMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survivalBiomed Res Int2014201490568024967412
- KongLMLiaoCGZhangYA regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasisCancer Re2014741437643778
- AfonsoJLongatto-FilhoABaltazarFCD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosisEur J Surg Oncol201137981181721733655
- XueYJLuQSunZXCD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancerMed Oncol20112841363137220509007
- ZhongWDLiangYXLinSXExpression of CD147 is associated with prostate cancer progressionInt J Cancer201213030030821328337
- RiethdorfSReimersNAssmannVHigh incidence of EMMPRIN expression in human tumorsInt J Cancer20061191800181016721788
- LiYXuJChenLHAb18G (CD147), a cancer-associated biomarker and its role in cancer detectionHistopathology200954667768719438743